244 related articles for article (PubMed ID: 453214)
41. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
[No Abstract] [Full Text] [Related]
42. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
Andrasch R; Schmitz-Schumann M
Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
[TBL] [Abstract][Full Text] [Related]
43. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
Kaik G
Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
[TBL] [Abstract][Full Text] [Related]
44. Theophylline pharmacokinetics in patients with mild or severe airway obstruction.
Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G
Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536
[TBL] [Abstract][Full Text] [Related]
45. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease.
Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908
[TBL] [Abstract][Full Text] [Related]
46. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
47. A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction.
Tedders JG; Thomas AK; Edwards G
Br J Clin Pract; 1976; 30(11-12):212-6. PubMed ID: 795447
[No Abstract] [Full Text] [Related]
48. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
49. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
Dettmer HH
Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
[No Abstract] [Full Text] [Related]
50. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
51. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
52. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
Ahrens J
Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
[TBL] [Abstract][Full Text] [Related]
53. Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.
Resar RK; Walson PD; Fritz WL; Perry DF; Barbee RA
Chest; 1979 Jul; 76(1):11-6. PubMed ID: 36261
[TBL] [Abstract][Full Text] [Related]
54. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
[TBL] [Abstract][Full Text] [Related]
55. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
Nolte D; Dusik B
Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
[TBL] [Abstract][Full Text] [Related]
56. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
[TBL] [Abstract][Full Text] [Related]
57. [Preliminary study on the pharmacokinetics of aminophylline controlled-release tablets].
Lin YG
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):1-3, 61. PubMed ID: 3197163
[No Abstract] [Full Text] [Related]
58. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
Taylor DR; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
[No Abstract] [Full Text] [Related]
59. Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.
Clark CJ; Boyd G
Br J Clin Pharmacol; 1980 Apr; 9(4):359-64. PubMed ID: 7378251
[TBL] [Abstract][Full Text] [Related]
60. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
Grambau GR; Johnson CE; Conlon PF; Weg JG
J Clin Pharmacol; 1985; 25(5):381-3. PubMed ID: 4031115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
